title: Nrf2 Modulates Host Defense during Streptococcus pneumoniae Pneumonia in Mice.
abstract: Nrf2 regulates the transcriptional response to oxidative stress. These studies tested the role of Nrf2 during Streptococcus pneumoniae pneumonia and identified Nrf2-dependent genes and pathways in lung tissue and in recruited neutrophils. Nrf2 null and wild type (WT) mice were studied at 6 and 24 h after instillation of S. pneumoniae or PBS. At 6 h, fewer neutrophils were recruited and the number of bacteria remaining in the lungs tended to be less (p = 0.06) in the Nrf2 null compared with WT mice. In uninfected lungs, 53 genes were already differentially expressed in Nrf2 null compared with WT mouse lungs, and gene sets involved in phagocytosis, Fc receptor function, complement, and Ig regulation are enhanced in PBS-treated Nrf2 null gene profiles compared with those of WT mice. These results suggest that initial host defense is enhanced in Nrf2 null mice, resulting in less recruitment of neutrophils. At 24 h, neutrophil recruitment was greater. The percentages of early apoptotic and late apoptotic/necrotic neutrophils were similar. At increasing inoculum numbers, mortality rates strikingly increased from 15 to 31 and 100% in Nrf2 null mice, whereas all WT mice survived, and Nrf2 null mice had a defect in clearance, particularly at the intermediate dose. The mortality was due to enhanced lung injury and greater systemic response. Gene profiling identified differentially regulated genes and pathways in neutrophils and lung tissue, including those involved in redox stress response, metabolism, inflammation, immunoregulatory pathways, and tissue repair, providing insight into the mechanisms for the greater tissue damage and increased neutrophil accumulation.
authors: Center for Airways Disease, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599; Marsico Lung Institute, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599;
authors: John C
authors: JC
authors: Gomez
authors: Marsico Lung Institute, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599; Cystic Fibrosis/Pulmonary Research and Treatment Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599; and.
authors: Hong
authors: H
authors: Dang
authors: Center for Airways Disease, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599; Marsico Lung Institute, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599;
authors: Jessica R
authors: 0000-0002-1145-2235
authors: JR
authors: Martin
authors: Center for Airways Disease, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599; Marsico Lung Institute, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599; Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599 cmd@med.unc.edu.
authors: Claire M
authors: CM
authors: Doerschuk
mesh_terms: D000818:Animals; D017209:Apoptosis / Q000276:immunology; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D051267:NF-E2-Related Factor 2 / Q000172:deficiency / Q000378:metabolism*; D009504:Neutrophils / Q000276:immunology / Q000378:metabolism / Q000473:pathology; D011018:Pneumonia, Pneumococcal / Q000276:immunology* / Q000378:metabolism*; D013296:Streptococcus pneumoniae / Q000276:immunology* / Q000378:metabolism*
chemical_list: D051267:NF-E2-Related Factor 2; C495636:Nfe2l2 protein, mouse